CY1117420T1 - A crystalline form of its (R) -7-chloro-N- (quinuclidin-3-yl) benzene [B] thiophene-2-carboxamide monohydrate hydrochloride - Google Patents

A crystalline form of its (R) -7-chloro-N- (quinuclidin-3-yl) benzene [B] thiophene-2-carboxamide monohydrate hydrochloride

Info

Publication number
CY1117420T1
CY1117420T1 CY20161100343T CY161100343T CY1117420T1 CY 1117420 T1 CY1117420 T1 CY 1117420T1 CY 20161100343 T CY20161100343 T CY 20161100343T CY 161100343 T CY161100343 T CY 161100343T CY 1117420 T1 CY1117420 T1 CY 1117420T1
Authority
CY
Cyprus
Prior art keywords
quinuclidin
thiophene
chloro
benzene
crystalline form
Prior art date
Application number
CY20161100343T
Other languages
Greek (el)
Inventor
Patricia Oliver-Shaffer
Gideon Shapiro
Richard Chesworth
Muneki Kishida
Takayuki Ishige
Original Assignee
Forum Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11721413.0A external-priority patent/EP2571874B1/en
Application filed by Forum Pharmaceuticals Inc. filed Critical Forum Pharmaceuticals Inc.
Publication of CY1117420T1 publication Critical patent/CY1117420T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Κρυσταλλικές Μορφές I και II του μονοένυδρου υδροχλωριδίου του (R)-7-χλωρο-Ν-(κινουκλιδιν-3-υλο)βενζο[b]θειοφαινο-2-καρβοξαμιδίου και συνθέσεις, μέθοδοι παρασκευής και θεραπευτικές χρήσεις αυτών περιγράφονται.Crystalline Forms I and II of (R) -7-chloro-N- (quinuclidin-3-yl) benzo [b] thiophene-2-carboxamide hydrochloride monohydrate and compositions, methods of preparation and therapeutic uses thereof are described.

CY20161100343T 2010-05-17 2016-04-26 A crystalline form of its (R) -7-chloro-N- (quinuclidin-3-yl) benzene [B] thiophene-2-carboxamide monohydrate hydrochloride CY1117420T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34536310A 2010-05-17 2010-05-17
US35209210A 2010-06-07 2010-06-07
EP11721413.0A EP2571874B1 (en) 2010-05-17 2011-05-17 A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate

Publications (1)

Publication Number Publication Date
CY1117420T1 true CY1117420T1 (en) 2017-04-26

Family

ID=58606681

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100343T CY1117420T1 (en) 2010-05-17 2016-04-26 A crystalline form of its (R) -7-chloro-N- (quinuclidin-3-yl) benzene [B] thiophene-2-carboxamide monohydrate hydrochloride

Country Status (1)

Country Link
CY (1) CY1117420T1 (en)

Similar Documents

Publication Publication Date Title
CY1120435T1 (en) PHARMACEUTICAL FORMS INCLUDING CRYSTAL FORMS OF HYDROCHLORIC MONHYDROCHLORIDE (R) -7-CHLORO-N- (CINOCLIDINO-3-YL) V-2-YL
CY1118379T1 (en) DISEASES OF USVITIS C
CY1120032T1 (en) PYRAZYLIC AND PYRIMIDYLIC TRICYCLIC NONS AS ANTIOXIDATORS INFLAMMATORS
NO20091395L (en) New thiophene derivatives
EA201490228A1 (en) NEW DERIVATIVES OF TRIFTOROMETHYLOROXIAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE
CY1118662T1 (en) NEW BICYCLE PYRIDINONS
UA106636C2 (en) MORPHOLINOTIAZOLES AS A POSITIVE ALLOSTERIC ALPHA MODULATORS 7
UY33183A (en) INHIBITING COMPOUNDS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT
AU2013225533A8 (en) Amido spirocyclic amide and sulfonamide derivatives
CL2009000426A1 (en) Compounds derived from carbocyclyl / heterocyclyl-pyridin-2-yl-urea, bacterial topoisomerase iv inhibitors; pharmaceutical composition; and its use for the treatment of bacterial infections
CY1119798T1 (en) FORM IV IV Hydrochloride Ibabradine
DK2632493T3 (en) Drug Administration Compositions
UY34350A (en) DERIVATIVES OF PIRAZOLQUINOLINONA, ITS PREPARATION AND THERAPEUTIC USE.
BR112012022878A2 (en) compound, pharmaceutical composition, compound use and method of treatment
FR2959935B1 (en) ALCOHOL-RESISTANT ORAL PHARMACEUTICAL FORM
HK1186978A1 (en) Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative
BR112014005407A2 (en) compound, pharmaceutical composition, use of the compound or a pharmaceutically acceptable salt thereof, and method of treating an hcv infected patient
IL220894A (en) Active ingredient combinations comprising dihydrofuranone derivatives and abamectin, mixture/beneficial species combinations and kit comprising same and uses thereof
EA201201202A1 (en) ORAL PHARMACEUTICAL COMPOSITION CONTAINING DABIGATRANE EXTILE
IL230487B (en) 6-(n-(7-chloro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5- yl)methylsulfonamido)-5-cyclopropyl-2-(4-fluorophenyl)-n-methylbenzofuran-3-carboxamide compounds, pharmaceutically acceptable salts thereof and pharmaceutical composition comprising them
RS54158B1 (en) Amyloid binding agents
UY34314A (en) DERIVATIVES OF ANILINA, ITS PREPARATION AND ITS THERAPEUTIC APPLICATION.
EA201290077A1 (en) CONNECTIONS-801
EA201201109A1 (en) ELECTRIC WOOD IN THIN-CUT CRYSTALLINE FORM AND PHARMACEUTICAL COMPOSITION CONTAINING
BR112013023575A8 (en) octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these